trial · primary record
Calcium electroporation
Bladder Tumors
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 20 |
| Primary completion | 2030-04-01 |
| Primary endpoint | Safety within 3 months post-treatment assessed by adverse and serious adverse events. |
| Registry ID | NCT07555769 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:48.054Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07555769
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.